Year: 2019

Reference is made to the announcement today concerning the recommended voluntary offer (the “Offer”) for all shares of Data Respons ASA (the “Company”) of NOK 48 per share, to be made by AKKA Technologies.As follows from the announcement, all board members holding shares in the Company and certain management members have, subject to fulfillment of certain terms and conditions, undertaken to pre-accept the Offer. This includes:ERIK LANGAKER, Chairman of the Board (416 746 shares)JANNE T. MORSTØL, Board member (4 000 shares)ULLA-BRITT FRÄJDIN-HELLEQVIST, Board member (10 000 shares)MARTIN BURKHALTER, Board member (3 000 shares)MARIUS WESTGAARD, Board member (1 047 shares)KENNETH RAGNVALDSEN, CEO (360 595 shares)RUNE WAHL, CFO (155 095 shares)JØRN E. TOPPE, MD Solutions (123 965...

BOSTON and CARLSBAD, Calif., Dec. 18, 2019 (GLOBE NEWSWIRE) — Akcea Therapeutics, Inc. (NASDAQ: AKCA), a majority-owned affiliate of Ionis Pharmaceuticals, Inc., and Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), today announced that, following a strategic portfolio decision by Novartis not to exercise its option, Akcea has retained rights to develop and commercialize AKCEA-APOCIII-LRx.“AKCEA-APOCIII-LRx has advanced rapidly in the past year and we are excited to drive the development and commercial strategy for this drug. We plan to focus our efforts on developing AKCEA-APOCIII-LR, for familial chylomicronemia syndrome, or FCS, plus other indications that could be positively impacted by reducing APOCIII and triglycerides. We look forward to seeing the results from our Phase 2 study of AKCEA-APOCIII-LRx early in 2020,”...

CALGARY, Alberta, Dec. 18, 2019 (GLOBE NEWSWIRE) — Pengrowth Energy Corporation (“Pengrowth” or the “Company”) (TSX:PGF, OTCX:PGHEF) today announced the approval of its previously announced  acquisition by Cona Resources Ltd. (the “Purchaser”), a portfolio company of Waterous Energy Fund, by way of a plan of arrangement (the “Arrangement”) under the Business Corporations Act (Alberta), at its special meetings of shareholders and secured debt holders held earlier today.At the special meeting of the Company’s shareholders, a total of 308,298,767 common shares were voted in person and by proxy, representing 55.04% of its issued and outstanding common shares. The Arrangement was approved by 87.25% of the votes cast by shareholders at the special meeting.At the special meeting...

VANCOUVER, British Columbia, Dec. 18, 2019 (GLOBE NEWSWIRE) — via NetworkWire: Wildflower Brands Inc. (CSE: SUN, OTC:WLDFF) (the “Company”) is pleased to announce revenue for the fiscal year ending June 30, 2019 of $7.1M – a 400% increase over revenues of $1.4M in 2018.  The Company began aggressively marketing its CBD Wellness products during the fiscal year, culminating with the launch of its products in June 2019 at Dillard’s, an American department retail chain with over 290 stores in 29 states. Highlights for the year ending June 30, 2019 (with comparisons to the prior year except as otherwise noted) include the following:Sales of $7,085,223 (2018: $1,408,114), including licensing fees from sales through our partner in the Washington State I-502 market, US nationwide e-commerce sales,...

TORONTO, Dec. 18, 2019 (GLOBE NEWSWIRE) — Faircourt Asset Management Inc., as Manager of the Faircourt Funds (NEO:FGX), (NEO:FCS.UN), is pleased to announce the monthly distributions payable on the Shares and Trust Units of the below listed Funds.      Faircourt Asset Management Inc. is the Investment Advisor for Faircourt Gold Income Corp. and Faircourt Split Trust. This press release is not for distribution in the United States or over United States wire services.For further information on the Faircourt Funds, please visit www.faircourtassetmgt.com or please contact 1-800-831-0304.You will usually pay brokerage fees to your dealer if you purchase or sell Units of the Trust on the NEO Exchange or other alternative Canadian trading system (an “exchange”). If the Units are purchased or sold on...

CHICAGO, Dec. 18, 2019 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. today announced that it has priced an initial public offering of 1,111,112 shares of its common stock at $8.00 per share. The shares are expected to begin trading on the Nasdaq Capital Market on December 19, 2019 under the symbol “MNPR.”  The offering is expected to close on December 23, 2019, subject to the satisfaction of customary closing conditions. In addition, the underwriters have been granted a 30-day option to purchase up to an additional 166,666 shares.JonesTrading Institutional Services LLC acted as Lead Bookrunning Manager and Brookline Capital Markets, a division of Arcadia Securities, LLC, acted as Co-Manager for the offering.The offering of these securities will be made only by means of a prospectus. Copies of the final prospectus,...

TORONTO, Dec. 18, 2019 (GLOBE NEWSWIRE) — Itafos (TSX VENTURE: IFOS) (the “Company”) announced today that it has entered into a binding letter of intent with CL Fertilizers Holding LLC (“CLF”) for a US$36,000,000 capital raise through a non-brokered private placement financing of US$15,000,000 and an amendment to increase the availability of a previously issued unsecured subordinated promissory note by US$21,000,000. The proceeds of the capital raise are expected to be used to fund general working capital and capital expenditure needs of the Company and its subsidiaries.Pursuant to the letter of intent, CLF will subscribe for up to 38,076,923 shares in the capital of the Company (the “Subject Shares”) at an offering price of CAD$0.52 per share on a non-brokered private placement basis, for aggregate...